Labour Vows to Achieve NHS Cancer Targets Missed Since 2015 in 10-Year Plan
Labour has pledged a robust commitment to fulfill all NHS cancer waiting time targets, many of which have been unmet for over a decade. This initiative is part of a comprehensive 10-year plan aimed at enhancing cancer care across the UK.
New National Cancer Plan Overview
The anticipated National Cancer Plan, set for unveiling on Wednesday, promises significant advancements in cancer diagnosis and treatment.
- Diagnosis or exclusion of cancer within 28 days for 75% of patients.
- 96% of patients to start treatment within 31 days of a doctor’s recommendation.
- 85% to be treated within 62 days of a referral.
- Increase in robotic-assisted procedures and genomic testing for personalized treatments.
Government Goals by 2029
By 2029, the government aims for that:
- 75% of patients diagnosed from 2025 will be cancer-free or living well after five years, a rise from the current 60%.
Challenges and Expert Opinions
Health and Social Care Secretary Wes Streeting, a cancer survivor himself, emphasized that survival rates should not depend on individual circumstances. However, experts warn that achieving these ambitious targets will require substantial investment and scaling of the healthcare workforce.
Richard Evans, Chief Executive of the Society of Radiographers, highlighted the shortcomings of previous cancer plans due to inadequate funding. “Nothing will happen without investment,” he stated.
Current Statistics on NHS Performance
As of November 2025, the NHS did not meet the 62-day treatment target established in 2000, with only 70% compliance. Current statistics include:
- 76.5% of patients diagnosed or excluded within 28 days.
- 91.7% commenced treatment within 31 days.
Looking Ahead
The new plan is set to increase robotic-assisted procedures from 70,000 to 500,000 by 2035 and provide an additional 9.5 million cancer tests by 2029. Increased access to genomic testing is also expected, enhancing treatment personalization.
Conclusion
Despite the ambitious nature of the goals laid out, experts like Sarah Scobie from the Nuffield Trust caution that significant financial backing and structural improvements are crucial. Without these, achieving world-leading cancer outcomes in the UK will remain a formidable challenge.
